Alkyl phospholipid perifosine induces myeloid hyperplasia in a murine myeloma model

This publication has 29 references indexed in Scilit:

• Coadministration of Histone Deacetylase Inhibitors and Perifosine Synergistically Induces Apoptosis in Human Leukemia Cells through Akt and ERK1/2 Inactivation and the Generation of Ceramide and Reactive Oxygen Species
  Cancer Research, 2005
• A Phase I Trial of Perifosine (NSC 639966) on a Loading Dose/Maintenance Dose Schedule in Patients with Advanced Cancer
  Clinical Cancer Research, 2004
• Alkyl-lysophospholipids as anticancer agents and enhancers of radiation-induced apoptosis
  International Journal of Radiation Oncology*Biology*Physics, 2001
• Increases in leucocyte and platelet counts induced by the alkyl phospholipid hexadecylphosphocholine
  European Journal Of Cancer, 1994
• Phase II study of daily oral miltefosine (hexadecylphosphocholine) in advanced colorectal cancer
  European Journal Of Cancer, 1993
• Phase II study of oral miltefosine in patients with squamous cell head and neck cancer
  European Journal Of Cancer, 1993
• Phase II study of miltefosine (Hexadecylphosphocholine) in advanced soft tissue sarcomas of the adult— An EORTC Soft Tissue and Bone Sarcoma Group study
  European Journal Of Cancer, 1993
• A dose-finding study of miltefosine (hexadecylphosphocholine) in patients with metastatic solid tumours
  Zeitschrift für Krebsforschung und Klinische Onkologie, 1992
• Hexadecylphosphocholine, a New Ether Lipid Analogue Studies on the Antineoplastic Activity in Vitro and in Vivo
  Acta Oncologica, 1988
• Characterization of the antitumor activity of hexadecylphosphocholine (D 18506)
  European Journal of Cancer and Clinical Oncology, 1988